Search

Your search keyword '"Gutiérrez V"' showing total 1,042 results

Search Constraints

Start Over You searched for: Author "Gutiérrez V" Remove constraint Author: "Gutiérrez V"
1,042 results on '"Gutiérrez V"'

Search Results

1. Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

2. Figuras del sujeto

3. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

4. Overview of IFMIF-DONES diagnostics: Requirements and techniques

5. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

6. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

8. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

12. Notas para Preparar Ejemplares para el Herbario

13. Clasificación Moderna de las Plantas

14. Pyroclastic Density Currents at Volcán de Colima

20. P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial

22. Legume consumption is inversely associated with type 2 diabetes incidence in adults: A prospective assessment from the PREDIMED study

26. Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

27. Influencia de la aplicación vía foliar de ácido oxálico y melatonina sobre la productividad y las características de calidad en cereza tardía

28. Mejora de la firmeza de cerezas mediante pulverización foliar con melatonina

44. A Method for Patient-specific Assessment of Abdominal Aortic Aneurysm Rupture Risk Based on Geometric Biomechanics Factors. Clinical Validation Test

45. P105 - Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

46. OP 5.3 – 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption

49. Pensamiento Complejo en la Medicina Tradicional

Catalog

Books, media, physical & digital resources